Glenmark Pharmaceuticals’ arm launches Adapalene Gel USP in new pump packs

Glenmark Pharmaceuticals’ subsidiary -- Glenmark Therapeutics Inc., USA, (Glenmark) has launched Adapalene Gel USP, 0.1% (OTC) in new pump packs. Glenmark’s Adapalene Gel USP, 0.1% can be compared to the active ingredient of Differin Gel, 0.1%. According to Nielsen syndicated data for the latest 52-week period ending September 5, 2026, the Differin Gel, 0.1% (OTC) market achieved annual sales of around $45.8 million.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.